During the July 19 meeting of the Advisory Council on Alzheimer’s Research, Care, and Services, NIA Director Richard J. Hodes, M.D., unveiled NIH’s FY 2023 Professional Judgment Budget for Alzheimer’s Disease and Related Dementias. “Transforming Research to Prevent, Detect, Treat, and Provide Better Care for Dementia” provides an estimate of the funds needed to enable NIH to fully pursue scientific opportunities toward effective diagnostics, preventions, and treatments for Alzheimer’s and related dementias. The report also features highlights of recent NIH-supported scientific progress to:
- Identify and test new drug candidates and work to repurpose treatments that are already approved for other illnesses for their possible effectiveness in treating dementia;
- Advance comprehensive models of care and search for ways to improve the overall quality of care, life, and caregiving for people living with dementia and their care partners;
- Develop effective, less invasive diagnostic and detection methods through biomarker research;
- Explore healthy behaviors that may reduce the risk of dementia; and
- Improve our understanding of the role of genetics and other disease mechanisms.
NIH also updated its AD+ADRD Research Implementation Milestones database to showcase funding initiatives, accomplishments, and highlights of progress toward accomplishing the National Alzheimer’s Plan goal of effectively treating or preventing Alzheimer’s and related dementias by 2025.